Company intelligence / Profile preview
Hanlim Pharm
Seoul, Seoul, South Koreahanlim.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Hanlim Pharm has a diverse pipeline, including IMDs, NCEs, and biologics. Notably, HL401 for systemic lupus erythematosus is in preclinical or early clinical development; HL301 (acute bronchitis), HL217 (AMD), and HL237 (rheumatoid arthritis) are at various phases of development. The company emphasizes ethical drugs, ophthalmic products, and combination therapies[3][5].
- Therapeutic areas
- ImmunologyEndocrinologyOphthalmologyGastroenterologyPulmonology
- Modalities
- Small moleculeBiologicMesenchymal stem cell therapy
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →03
Partnerships
CORESTEM (joint research in lupus treatment)[9]Sanofi (historic sales alliance)[9]Ethypharm (historic technical alliance)[9]GADOR (historic technical alliance)[9]GRAAF (historic technical alliance)[9]
Beyond the preview
Go deeper on Hanlim Pharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hanlim Pharm.